You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
愛朋醫療(300753.SZ):公司2023年度研發投入佔營收比例為8.66%
格隆匯 07-19 18:10

格隆匯7月19日丨愛朋醫療(300753.SZ)在投資者互動平台表示,公司自上市以來,一直重視研發技術投入和研發規劃,並持續優化研發組織架構。公司2023年度研發投入佔營收比例為8.66%,已搭建以核心主營業務為主的縱向產品管理集,以產品管理平台和專項技術為橫向支撐的研發組織架構體系。並將逐步梳理現有在研產品,聚焦核心技術領域,加強外部產學研等戰略合作,以嚴格的產品項目制提升產品開發效率。通過主營業務產品的持續優化升級和核心技術的硬實力打造,守正創新。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account